White coat hypertension - Haemodynamic mechanisms and risk assessment;Kontorhypertensjon

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 5, 1999, Pages 667-670

  Soma, Johannes ^a   Dahl, Ketil Jamte ^b   Widerøe, Tor Erik ^c  

^a Regionsykehuset i Trondheim   (Norway)

^b Legepraksis   (Norway)

^c Regionsykehuset i Trondheim   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; VASODILATATION;

AGE FACTORS; AGED; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; PHYSICIANS' OFFICES; RISK FACTORS; VASODILATION;

EID: 0033585653     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Ayman D, Goldshine AD. Blood pressure determinations by patients with essential hypertension I. The difference between clinic and home readings before treatment. Am J Med Sci 1940; 200: 465-74.
2. Alam GM, Smirk FH. Casual and basal blood pressures II. In essential hypertension. Br Heart J 1943; 5: 156-60.
3. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966; 34: 279-98.
4. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R et al. White coat hypertension and white coat effect: similarities and differences. Am J Hypertens 1995; 8: 790-8.
5. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension. JAMA 1988; 259: 225-8.
6. Widerøe TE, Dahl KJ. Mild hypertensjon. Tidsskr Nor Lægeforen 1998; 118: 2335-8.
7. Verdecchia P, Porcellati C. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis. Am J Hypertens 1993; 6: 207-10.
8. O'Brien E, Staessen J. Normotension and hypertension as defined by 24-hour ambulatory blood pressure monitoring. Blood Press 1995; 4: 266-82.
9. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama study. Hypertension 1998; 32: 255-9.
10. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
11. Eich RH, Cuddy RP, Smulyan H, Lyons RH. Hemodynamics in labile hypertension: a followup study. Circulation 1966; 34: 299-307.
12. Parati G, Pomodossi G, Albin F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of targetorgan damage in hypertension. J Hypertens 1987; 5: 93-8.
13. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G et al. White coat hypertension: a selection bias? J Hypertens 1998; 16: 977-84.
14. Cardillo C, De Felice F, Campia U, Folli G. Psychological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993; 21: 836-44.
15. Goldstein DS. Stress response patterns. I: Goldstein DS, red. Stress, catecholamines and cardiovascular disease. New York: Oxford University Press, 1995: 287-328.
16. Soma J, Aakhus S, Dahl K, Slordahl S, Wiseth R, Wideroe TE et al. Hemodynamics in white coat hypertension compared to ambulatory hypertension and normotension. Am J Hypertens 1996; 9: 1090-8.
17. Lermann CE, Brody DS, Hui T, Lazaro C, Smith DG, Blum MJ. The white-coat hypertension response: prevalence and predictors. J Gen Intern Med 1989; 4: 226-31.
18. Silagy CA, McNeil JJ, McGrath BP, Parish S. Is isolated systolic hypertension a «white coat» phenomenon in the elderly (short communication). Clin Exp Pharmacol Physiol 1992; 19: 291-3.
19. Thijs L, Amery A, Clement D, Cox J, de Cort P, Fagard R et al. Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension. J Hypertens 1992; 10: 693-9.
20. Wittenberg C, Zabludovski JR, Rosenfeld JB. Overdiagnosis of hypertension in the elderly. J Hum Hypertens 1992; 6: 349-51.
21. Trenkwalder P, Plaschke M, Steffes-Tremer I, Lydtein H. «White coat» hypertension and alerting reaction in elderly and very elderly patients. Blood Press 1993; 2: 262-71.
22. Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE et al. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8: 978-86.
23. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A et al. Effects of blood pressure measurements by the doctor on the patients blood pressure and heart rate. Lancet 1983; 2: 695-7.
24. Westerhof N, Elzinga G, Sipkema P. An artificial arterial system for pumping hearts. J Appl Physiol 1971; 31: 776-81.
25. Yin FCP. Aging and vascular impedance. I: Yin FCP, red. Ventricular/vascular coupling: clinical, physiological, and engineering aspects. New York: Springer-Verlag, 1987: 115-39.
26. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens 1992; 10 (suppl 6): 73-7.
27. Rutan G. A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol 1989; 427: 663-73.
28. Soma J, Aakhus S, Angelsen BAJ, Skjærpe T. Influence of body size and left ventricular ejection dynamics on total arterial compliance determined using doppler echocardiography and subclavian artery pulse tracings in healthy humans. Blood Press 1998; 7: 239-46.
29. 1-adrenergic receptor blockade and angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1998; akscptert for publisering.
30. Myers MG. Systolic hypertension and the white coat phenomenon. Am J Hypertens 1996; 9: 938-40.
31. Sarnoff SJ, Mitchell JH, Gilmore JP, Remensnyder JP. Homeometric autoregulation in the heart. Circ Res 1960; 8: 1077-91.
32. Milnor WR. Properties of the vascular wall. 1: Collins N, red. Hcmodynamics. 2. utg. Baltimore: Williams & Wilkins, 1989: 58-95.
33. Smulyan H, Marchais SJ, Pannier B, Gucrin AP, Safar ME, London GM. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol 1998; 31: 1103-9.
34. Adamopoulos PN, Chrysanthakopoulis SG, Frohlich ED. Systolic hypertension: nonhomogeneous disease. Am J Cardiol 1975; 36: 697-701.
35. Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, and cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 1998; 16: 577-83.
36. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation 1961; 23: 697-713.
37. Kannel W. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis 1974; 17: 5-24.
38. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram - prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71: 89-105.
39. Casale P, Devereux R, Milner M, Zullo G, Harshfield GA, Pickering TG et al. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
40. Kannel W, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971; 27: 335-46.
41. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.
42. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Lack of association between blood pressure variability and left ventricular mass in essential hypertension. Am J Hypertens 1998; 11: 515-22.
43. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-8.
44. Ohkubu T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N et al. Home blood pressure measurements has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-5.
45. White WB, Schulman P, McCabe E, Dey HM. Average daily blood pressure, not office blood pressure determines cardiac function in patients with hypertension. JAMA 1989; 261: 873-7.
46. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993; 6: 282-6.
47. Soma J, Widerøe TE, Dahl K, Rossvoll O, Skjærpe T. Left ventricular systolic and diastolic function assessed with two-dimensional and Doppler echocardiography in «white coat» hypertension. J Am Coll Cardiol 1996; 28: 190-6.
48. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Folio M, Zanata G et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the harvest study. Hypertension 1998; 31: 57-63.
49. Julius S, Mcjia A, Jones K, Krause L, Schork N, van de Ven C et al. «White coat» versus «sustained» borderline hypertension in Tecumsch, Michigan. Hypertension 1990; 16: 617-23.
50. Lund-Johansen P, Omvik P. Hemodynamic patterns of untreated hypertensive disease. I: Laragh JH, Brenner BM, red. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1990: 305-27.
51. Muscholl MW, Hense H-W, Bröckel U, Döring A, Riegger GAJ, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional study. BMJ 1998; 317: 565-70.
52. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991; 265: 3255-64.
53. Howard PA. Treating isolated systolic hypertension in the elderly. Annals Pharmacother 1994; 28: 367-73.
54. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
55. Houston MC. New insights and approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J 1989; 117: 911-51.